Gabriele Gillessen-Kaesbach, Raoul C Hennekam, Marco Tartaglia, Bernd Wollnik, Carlos Lopez-Otin, Humberto Arboleda, Gökhan Yigit, Gloria Velasco, Adrian Sandoval, Jenny Ortega, Antonio Novelli, Christian Müller, Shehla Mohammed, Thomas Krieg, Stefano Paolacci, Andrea Ciolfi, Alessandro Bruselles, Filippo Beleggia, Gonzalo Arboleda, Janine Altmüller, Mariel Alders, Lihadh Al-Gazali, Debora Bertola, Dido Carrero, Carlos E Arboleda-Bustos, Emanuele Bellacchio, Emanuele Agolini, Yun Li
Journal: Journal of medical genetics 2019;55(12):837-846
PMID: 30323018
BACKGROUND
Wiedemann-Rautenstrauch syndrome (WRS) is a form of segmental progeria presenting neonatally, characterised by growth retardation, sparse scalp hair, generalised lipodystrophy with characteristic local fatty tissue accumulations and unusual face. We aimed to understand its molecular cause.
METHODS
We performed exome sequencing in two families, targeted sequencing in 10 other families and performed in silico modelling studies and transcript processing analyses to explore the structural and functional consequences of the identified variants.
RESULTS
Biallelic variants were identified in eight affected individuals and monoallelic variants of the same gene in four other individuals. In the latter, lack of genetic material precluded further analyses. Multiple variants were found to affect transcript processing and were mostly located in deep intronic regions, making clinical suspicion fundamental to detection. While biallelic variants have been previously reported in 4H syndrome and adolescent-onset progressive spastic ataxia, recurrent haplotypes specifically occurring in individuals with WRS were detected. All WRS-associated POLR3A amino acid changes were predicted to perturb substantially POLR3A structure/function.
CONCLUSION
Biallelic mutations in , which encodes for the largest subunit of the DNA-dependent RNA polymerase III, underlie WRS. No isolated functional sites in POLR3A explain the phenotype variability in POLR3A-related disorders. We suggest that specific combinations of compound heterozygous variants must be present to cause the WRS phenotype. Our findings expand the molecular mechanisms contributing to progeroid disorders.
© Author(s) (or their employer(s)) 2018. No commercial re-use. See rights and permissions. Published by BMJ.
Medical:
Molecular Biology Databases:
Full Text Sources:
Other Literature Sources:
© Copyright 2026, Nutrition Evidence
We use cookies to improve your experience and analyze site traffic with Google Analytics. By continuing to use our site, you agree to our use of cookies. Learn more.